biotech » Trang Công Nghệ | Trangcongnghe.vn

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Globe Newswire

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Globenewswire -

Sarat Ventures Y Innovations Biotech Fund to Invest in Early-Stage Companies with a focus in Saudi Arabia and the MENA Region

Globe Newswire

Sarat Ventures Y Innovations Biotech Fund to Invest in Early-Stage Companies with a focus in Saudi Arabia and the MENA Region

Globenewswire -

Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

Globe Newswire

Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

Globenewswire -

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

Globe Newswire

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

Globenewswire -

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

Globe Newswire

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

Globenewswire -

Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation

Globe Newswire

Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation

Globenewswire -

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Globe Newswire

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Globenewswire -

XEM THÊM TIN MỚI